BILL (NYSE:BILL – Free Report) had its target price lowered by Canaccord Genuity Group from $175.00 to $100.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. BILL has been the subject of several other reports. UBS Group reaffirmed a buy rating […]
BILL (NYSE:BILL – Get Free Report) had its price target decreased by research analysts at Needham & Company LLC from $200.00 to $100.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 11.83% from […]
BILL (NYSE:BILL – Get Free Report) had its price target dropped by equities research analysts at Canaccord Genuity Group from $175.00 to $100.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 49.37% from the stock’s […]
BILL (NYSE:BILL – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of $1.64-1.97 for the period, compared to the consensus EPS estimate of $1.97. The company issued revenue guidance of $1.205-1.245 billion, compared to the consensus revenue estimate of $1.31 billion. BILL also updated […]
Wells Fargo & Company initiated coverage on shares of BILL (NYSE:BILL – Get Free Report) in a report issued on Tuesday, Briefing.com reports. The firm set an “overweight” rating and a $115.00 price target on the stock. Wells Fargo & Company‘s price objective indicates a potential upside of 28.21% from the stock’s previous close. BILL […]